|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7508 USD | -5.74% |
|
-7.31% | -46.75% |
| Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
| Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Lucid Diagnostics Inc.(NasdaqGM:LUCD) dropped from Russell 3000 Value Index
| 1st Jan change | Capi. | |
|---|---|---|
| -46.75% | 36.22M | |
| +72.44% | 12.33B | |
| -19.30% | 7.86B | |
| +2.18% | 5.77B | |
| +7.87% | 5.1B | |
| +20.28% | 4.29B | |
| -20.59% | 3.92B | |
| -41.57% | 2.2B | |
| -0.99% | 1.92B | |
| -1.66% | 1.76B |
LUCID DIAGNOSTICS INC. 
